Bonesupport Holding AB (publ)
BONEX
Rank in Stocks
#5723
Bonesupport Holding AB (publ) is an orthobiologics company that specializes in... Bonesupport Holding AB (publ) is an orthobiologics company that specializes in the development and commercialization of injectable bioceramic bone graft substitutes. These products are utilized for treating bone voids and are available internationally, including in Europe and North America. Among its key offerings are CERAMENT Bone Void Filler, a synthetic, injectable, moldable, and drillable solution comprising hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol. Additionally, the company provides CERAMENT G, an injectable ceramic bone graft substitute infused with gentamicin, and CERAMENT V, a synthetic bone void filler containing vancomycin. Bonesupport is also advancing preclinical product candidates focused on promoting bone regrowth. These future solutions are being developed for applications such as trauma, revision arthroplasty, chronic osteomyelitis, oncology, and bone and foot infections related to diabetes. Founded in 1999, the company maintains its headquarters in Lund, Sweden.
Share Price
$32.46
Last synced: 2026-11-11
Market Cap
$2.12B
Change (1 day)
1.20%
Change (1 year)
44.99%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bonesupport Holding AB (publ) (BONEX)
Category
Healthcare
EPS for Bonesupport Holding AB (publ) (BONEX)
EPS as of September 2026 TTM: $0.42
According to Bonesupport Holding AB (publ)'s latest financial reports, its current EPS (TTM) is $0.42. At the end of 2025 the company had an EPS of $0.23, an increase over its 2024 EPS of $0.19.
EPS history for Bonesupport Holding AB (publ) from 2014 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.42 | 81.22% |
| 2025 | $0.23 | 26.54% |
| 2024 | $0.19 | -50.50% |
| 2023 | $0.37 | -467.45% |
| 2022 | $-0.10 | -31.33% |
| 2021 | $-0.15 | -28.83% |
| 2020 | $-0.21 | -37.34% |
| 2019 | $-0.33 | -14.25% |
| 2018 | $-0.39 | -2.27% |
| 2017 | $-0.40 | 51.26% |
| 2016 | $-0.26 | 71.35% |
| 2015 | $-0.15 | 8.52% |
| 2014 | $-0.14 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | 547.79% |
US
|
|
| $4.09 | 881.29% |
IE
|
|
| $9.45 | 2,167.27% |
US
|
|
| $2.37 | 468.62% |
US
|
|
| $1.77 | 324.66% |
US
|
Questions about Bonesupport Holding AB (publ)'s earnings per share (EPS)
What is Bonesupport Holding AB (publ)'s earnings per share (EPS)?
Bonesupport Holding AB (publ)'s earnings per share (EPS) over the last twelve months is $0.42, as of Sep 2026.
What was Bonesupport Holding AB (publ)'s earnings per share (EPS) in 2025?
In 2025, Bonesupport Holding AB (publ)'s earnings per share (EPS) was $0.23, 21.05% more than in 2024 ($0.19).
How has Bonesupport Holding AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Bonesupport Holding AB (publ)'s earnings per share (EPS) was highest in 2023 ($0.37) and lowest in 2020 ($-0.21).
How does Bonesupport Holding AB (publ)'s earnings per share (EPS) compare with similar companies?
Bonesupport Holding AB (publ)'s earnings per share (EPS) ($0.42) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.